https://www.nxtpsychedelics.com/news/articles/psychedelics/wellbeing-subsidiary-kgk-science-submits-cta-for-phase-iia-clinical-trial/
Wellbeing Subsidiary KGK Science Submits CTA for Phase IIA Clinical Trial